Julen
Oyarzabal Santamarina
Ikertzailea 2018-(e)ra arte
University of Michigan Medical School
Ann Arbor, Estados UnidosUniversity of Michigan Medical School-ko ikertzaileekin lankidetzan egindako argitalpenak (1)
2024
-
AI is a viable alternative to high throughput screening: a 318-target study
Scientific Reports, Vol. 14, Núm. 1